NSC95682 (6-Bromo-2-hydroxy-3-methoxybenzaldehyde) |
| Catalog No.GC34111 |
NSC95682 (6-Bromo-2-hidroxi-3-metoxibenzaldehÍdo) (NSC95682) es un IRE-1α inhibidor con IC50 de 0,08 μ M, extraÍdo de la patente WO 2008154484 A1, IRE-1α compuesto inhibidor 3-5.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 20035-41-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
NSC95682 is an IRE-1α inhibitor with an IC50 of 0.08 μM, extracted from patent WO 2008154484 A1, IRE-lα inhibitor compound 3-5.
[1]. John Bruce Patterson, et al. Ire-1a inhibitors. WO 2008154484 A1
Review for NSC95682 (6-Bromo-2-hydroxy-3-methoxybenzaldehyde)
Average Rating: 5 (Based on Reviews and 36 reference(s) in Google Scholar.)
Review for NSC95682 (6-Bromo-2-hydroxy-3-methoxybenzaldehyde)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *